Travere therapeutics to present new filspari® (sparsentan) data at the national kidney foundation spring clinical meetings 2025

San diego--(business wire)---- $tvtx--travere's late-breaking oral presentation at nkf details partial and complete proteinuria remission data from the duplex study of filspari in fsgs.

TVTX Ratings Summary

TVTX Quant Ranking